Mervyn Turner

Président chez Lunac Therapeutics Ltd.

Profil

Mervyn J.
Turner is the founder of PrescribeWell, Inc. Current jobs include Chairman at Lunac Therapeutics Ltd., Director at PharmAkea, Inc., Director at EnGeneIC Pty Ltd., Director at Spinogenix, Inc., Director at Amydis, Inc., Director at SAB Sciences, Inc. since 2020, and Board of Strategic Advisor at Excel Medical Ventures LLC.
Former jobs include Director at Preventice Technologies, Inc., Director at Tunitas Therapeutics, Inc., Independent Director at Big Cypress Acquisition Corp., Independent Director at SAB Biotherapeutics, Inc., Independent Director at Adagene, Inc. from 2023 to 2025, Chief Strategy Officer & Senior Vice President at Merck & Co., Inc. in 2011, Chief Strategy Officer at Schering-Plough Corp.
in 2009, Advisor at Quaker Partners Management LP, and Chief Strategy Officer & SVP-Worldwide Licensing at Merck Sharp & Dohme Corp.
from 1999 to 2009.
Education includes a doctorate from The University of Sheffield.

Postes actifs de Mervyn Turner

Sociétés	Poste	Début
Excel Medical Ventures LLC	Consultant / Advisor	-
PharmAkea, Inc.	Directeur/Membre du Conseil	-
EnGeneIC Pty Ltd.	Directeur/Membre du Conseil	-
SAB Sciences, Inc.	Directeur/Membre du Conseil	16/12/2020
Lunac Therapeutics Ltd.	Président	-
Amydis, Inc.	Directeur/Membre du Conseil	-
Spinogenix, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Mervyn Turner

Sociétés	Poste	Fin
ADAGENE INC.	Directeur/Membre du Conseil	24/03/2025
MERCK & CO., INC.	Corporate Officer/Principal	03/10/2011
░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░